Latest Convertible Note Conversion News

Global Masters Fund Limited (GFL) reported a robust 19.8% total return for FY2025, surpassing the MSCI World Index, while unveiling strategic moves to diversify beyond Berkshire Hathaway into private growth and regional quality funds.

Austral Gold has received TSX Venture Exchange approval to issue 1,025,077 shares as repayment of accrued interest on convertible notes, following a recent principal conversion. This move reflects ongoing capital management efforts amid the company’s growth strategy.

Environmental Clean Technologies is set to convert a $1.13 million convertible note into equity, significantly reducing debt and freeing resources to advance its PFAS remediation technology.

Morella Corporation has locked in A$1.4 million in convertible note funding from key shareholders and directors, strengthening its financial position to advance critical minerals exploration and acquisitions.

Global Masters Fund Limited has released its quarterly report for Q3 2025, confirming steady convertible note conversions and a healthy loan-to-value ratio, underscoring its solid financial position and compliance.

Beonic Ltd has raised $4.27 million through convertible notes to fund its product development, repay upcoming debt, and advance its North African Airport Project.

Dotz Nano Limited reported a reduced half-year loss and significant progress in its Direct Air Capture technology, while navigating funding uncertainties with key investors.

BPH Global Limited reported a strong 161.7% revenue increase to nearly $288,000 for FY25, driven by new seaweed operations in Indonesia, yet the company remains in the red with a $1.3 million net loss. The firm continues to raise capital and integrate acquisitions as it charts a path forward.

Macarthur Minerals has provided updated details ahead of its 2025 AGM regarding share issuances and convertible note conversions that affect key shareholder voting power. The changes notably adjust the stakes of Gold Valley Yilgarn Pty Ltd and Copulos Group.

Vitrafy Life Sciences reported a 75% increase in FY25 sales driven by aquaculture and human health sectors, progressing its cryopreservation technology towards commercialisation in both unregulated and regulated markets in FY26.

Vitrafy Life Sciences reported strong FY25 progress with 75% sales growth, advanced cryopreservation technology development, and a robust cash position. The company outlines a clear commercialisation roadmap for FY26, including product launches and expanded U.S. operations.

Challenger Gold Limited reported a strong quarter with significant financing inflows boosting its cash reserves to nearly $27 million, ensuring operational funding for over six quarters. Despite ongoing cash outflows from operations and investing, the company’s liquidity position remains robust.